Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Sodium valproate [VLP] is chemically sodium-2-propyl pentanoate. It is the first line drug used in the treatment of primary generalized, partial, and myoclonic seizures. VLP mode of action is to increase the synthesis and decrease the metabolism of gamma-aminobutyric acid, thus stabilizing the electrical activity in the brain.